KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas. - Tarantelli C; Spriano F; Civanelli E; Aresu L; Risi G; Cannas E; Kayali O; Cascione L; Arribas AJ; Stathis A; Ko YH; Bertoni F (Cancers, 2025)